Filing Details
- Accession Number:
- 0001209191-15-025518
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-12 10:36:23
- Reporting Period:
- 2015-03-11
- Filing Date:
- 2015-03-12
- Accepted Time:
- 2015-03-12 10:36:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1516479 | Insys Therapeutics Inc. | INSY | Pharmaceutical Preparations (2834) | 510327886 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1235637 | Patrick Fourteau | C/O Insys Therapeutics, Inc. 444 South Ellis Street Chandler AZ 85224 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-03-11 | 10,000 | $59.94 | 70,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The weighted average sales price for the transaction reported was $59.9359, and the range of prices were between $59.50 to $60.15.
Billionaire Hedge Funds
